Search - tctmd.com

Displaying 821 - 840 of 6629

Sort: Relevancy | Date

Presentation NY Valves 2024

PRO: TMVR Is a Good Option for Functional MR

Presenter: Chet Rihal

June 06, 2024

Presentation NY Valves 2024

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

Presenter: Javed Butler

June 06, 2024

Presentation NY Valves 2024

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Presenter: Michael Joseph Rinaldi

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

Case 2: TAVR in MAC With Lampoon and Sapien – Step-by-step Approach and Clinical Outcomes

Presenter: Adam B. Greenbaum

June 06, 2024

Presentation NY Valves 2024

Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality?

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

Presenter: Jason H. Rogers

June 06, 2024

Presentation NY Valves 2024

Pro-Surgery

Presenter: James M. McCabe

June 06, 2024

Presentation NY Valves 2024

Pro-TMVR

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

What Is MAC? Incidence, Diagnosis, Grading, and Clinical Relevance: 2024 Updates

Presenter: Mackram F. Eleid

June 06, 2024

Presentation NY Valves 2024

EVOLVING TARGET: Arrhythmic Mitral Valve Prolapse – Surgical and Mechanistic Insights

Presenter: Michael A. Borger

June 06, 2024

Presentation NY Valves 2024

CONTROVERSY: Is there an Expanding Role for Mitral TEER in Primary MR?

Presenter: Joanna Chikwe

June 06, 2024

Presentation NY Valves 2024

Ping-Pong Technique to Avoid Left Main Occlusion During TAVI

Presenter: Vincenzo Cesario

June 06, 2024

Presentation NY Valves 2024

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

Presenter: Andrea Scotti

June 06, 2024

Presentation NY Valves 2024

Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve

Presenter: Isaac George

June 06, 2024

Presentation NY Valves 2024

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

Presenter: Joao L. Cavalcante

June 06, 2024

Presentation NY Valves 2024

T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial

Presenter: Brian K. Whisenant

June 06, 2024

Presentation NY Valves 2024

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Presenter: Azeem Latib

June 06, 2024

Presentation NY Valves 2024

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

Presenter: Jörg Hausleiter

June 06, 2024

Advertisement

PRO: TMVR Is a Good Option for Functional MR

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Case 2: TAVR in MAC With Lampoon and Sapien – Step-by-step Approach and Clinical Outcomes

Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality?

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

Pro-Surgery

Pro-TMVR

What Is MAC? Incidence, Diagnosis, Grading, and Clinical Relevance: 2024 Updates

EVOLVING TARGET: Arrhythmic Mitral Valve Prolapse – Surgical and Mechanistic Insights

CONTROVERSY: Is there an Expanding Role for Mitral TEER in Primary MR?

Ping-Pong Technique to Avoid Left Main Occlusion During TAVI

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content